Skip to content
Agentic OS
Menu

Intelligence / Services / Auditor Changes / CNBX Pharmaceuticals Inc.

Auditchanged auditor (SEC 8-K)1 Oct 2026

CNBX Pharmaceuticals Inc.

1 Oct 2026: Changed auditor (SEC 8-K) · Elkana Amitai CPA. Recorded in the SEC EDGAR full-text search.

View the source record

Filed
1 Oct 2026
Ticker
CNBX
Sector
Pharma and biotech
Sic
2834
Items
4.01, 9.01
Location
Bethesda, MD
State
Maryland
Country
United States
SEC CIK
1343009
Reference
0001683168-26-007522
Former
Elkana Amitai CPA
Event
Auditor dismissed
Summary
The Board of Directors of CNBX Pharmaceuticals Inc. (the "Company") has dismissed Elkana Amitai CPA ("Former Accounting Firm") as its independent registered public accounting firm, effective as of September 28th, 2026.
What this signal means

A new auditor brings a new audit plan: controls, accounting advisory, tax and finance-systems work are re-tendered; a resignation often signals reporting problems that need fixing fast.

  1. Auditor dismissed leads with 57 of 94, then Auditor resigned or declined to stand (25).
  2. 22 added in the 30 days to 19 Nov 2026.
Reach them with AOS

Find the decision makers at CNBX Pharmaceuticals Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this audit signal, for your approval.

Start free

More in Auditor dismissed

Auditor Changes

See all

Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 4.01 (change in the registrant's certifying accountant) filed with the SEC in the last 90 days. Outgoing and incoming firms are read from the filing's wording; amendments and exhibit letters are not counted. AOS shows what the public record says; it does not verify or endorse the company.